Article
Translating Germline Cancer Risk into Precision Prevention.
Cell - 9 Feb 2017
Yurgelun Matthew B, Chenevix-Trench Georgia, Lippman Scott M
Abstract excerpt
Study of the biology of tumors caused by germline mutations has led to recent paradigm-changing therapy and is driving precision prevention efforts, including immune oncology and early detection research. Here, we explore recent biologic advances that are redefining the spectrum of cancers linked to various hereditary predisposition syndromes and can be leveraged to improve personalized risk assessment and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
